BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1614602)

  • 21. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group.
    Lancet; 1990 Jul; 336(8707):71-5. PubMed ID: 1975322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracerebral hemorrhage after thrombolytic therapy managed with ventricular drainage.
    Al-Khawaja D; Eslick GD; Fuller SJ; Seex K
    J Clin Neurosci; 2007 Sep; 14(9):898-900. PubMed ID: 17660059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator.
    Kase CS; Pessin MS; Zivin JA; del Zoppo GJ; Furlan AJ; Buckley JW; Snipes RG; LittleJohn JK
    Am J Med; 1992 Apr; 92(4):384-90. PubMed ID: 1558085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute anuric renal failure: a complication of combined thrombolytic and antithrombotic therapy.
    Toupin LR; Blanchard DG
    Int J Cardiol; 1993 Jul; 40(3):283-5. PubMed ID: 8225663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Danger of treatment protocols.
    Cucchiara B; Messé S; Kasner SE
    Stroke; 2003 May; 34(5):e19. PubMed ID: 12690208
    [No Abstract]   [Full Text] [Related]  

  • 26. Conservative management complications after thrombolytic therapy.
    Mohler ER; Stark KS; Kent KM
    Am Heart J; 1991 Feb; 121(2 Pt 1):591-3. PubMed ID: 1899317
    [No Abstract]   [Full Text] [Related]  

  • 27. Spontaneous subperiosteal orbital hemorrhage following thrombolytic therapy for myocardial infarction.
    Diatchuk V; Rehany U; Rumelt S
    Ophthalmic Plast Reconstr Surg; 2007; 23(6):482-4. PubMed ID: 18030123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction.
    Hasdai D; Califf RM; Thompson TD; Hochman JS; Ohman EM; Pfisterer M; Bates ER; Vahanian A; Armstrong PW; Criger DA; Topol EJ; Holmes DR
    J Am Coll Cardiol; 2000 Jan; 35(1):136-43. PubMed ID: 10636271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolytic therapy for stroke.
    Brott T; Broderick J; Kothari R
    Curr Opin Neurol; 1994 Feb; 7(1):25-35. PubMed ID: 8173673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator.
    Ben-Chitrit S; Korzets Z; Hershkovitz R; Bernheim J; Schneider M; Bernheim J
    Nephrol Dial Transplant; 1994; 9(4):428-30. PubMed ID: 8084460
    [No Abstract]   [Full Text] [Related]  

  • 31. Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience.
    Sloan MA; Price TR; Terrin ML; Forman S; Gore JM; Chaitman BR; Hodges M; Mueller H; Rogers WJ; Knatterud GL; Braunwald E
    Stroke; 1997 Jun; 28(6):1107-14. PubMed ID: 9183334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thrombolytic therapy for myocardial infarction in oral anticoagulation].
    Pizzulli L; Lüderitz B
    Dtsch Med Wochenschr; 1996 Mar; 121(13):424. PubMed ID: 8681737
    [No Abstract]   [Full Text] [Related]  

  • 33. [A randomized study of streptokinase and recombinant tissue plasminogen activator, with and without heparin, in patients with acute myocardial infarction. The results of GISSI-2/International tPA/SK Mortality Trial].
    Steffensen R; Sandøe E
    Ugeskr Laeger; 1991 Oct; 153(41):2880-3. PubMed ID: 1949301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators.
    Berkowitz SD; Granger CB; Pieper KS; Lee KL; Gore JM; Simoons M; Armstrong PW; Topol EJ; Califf RM
    Circulation; 1997 Jun; 95(11):2508-16. PubMed ID: 9184581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ischemic ictus during thrombolytic treatment in acute myocardial infarct].
    Seijo-Martínez M; Pais A; Castro del Río M; Silva-Martínez M
    Rev Neurol; 2000 Oct 16-31; 31(8):798-9. PubMed ID: 11082894
    [No Abstract]   [Full Text] [Related]  

  • 36. Paraplegia subsequent to administration of tissue plasminogen activator and intravenous heparin following myocardial infarction--a case report.
    DePorto R; Ahn JH; Gianutsos JG
    J Spinal Cord Med; 2000; 23(2):150-2. PubMed ID: 10914357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [CNS hemorrhage after drug induced thrombolysis in suspected myocardial infarction].
    Rabow L; Bergenheim T; Fagerlund M
    Lakartidningen; 1991 Feb; 88(7):492, 494-5. PubMed ID: 1999997
    [No Abstract]   [Full Text] [Related]  

  • 38. Intracerebral haemorrhage after thrombolytic therapy for acute myocardial infarction.
    More RS; Vincent R
    Postgrad Med J; 1992 Oct; 68(804):800-3. PubMed ID: 1461851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful outcome after evacuation of intracranial hematoma following thrombolysis in acute myocardial infarction.
    Al Khuwaitir TS; Wani BA; Dawood HA; Khan MA
    Saudi Med J; 2005 Jan; 26(1):130-2. PubMed ID: 15756370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombolytic therapy in acute ischemic stroke.
    Clark WM; Lyden PD; Madden KP; Zivin JA
    N Engl J Med; 1997 Jan; 336(1):65-6; author reply 66-7. PubMed ID: 8984333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.